We partner with leading universities, hospitals, and HCPs to investigate our novel NanoCelle® therapies.
The ENHANCE Study
A national observational study aimed to investigate the ability of NanoCelle® THC/CBD
to safely reduce the severity of chronic conditions and enhance quality of life.
Patient recruitment is planned to start in March 2023.
CORPORATE OFFICES
11-13 LORD ST, BOTANY
BUILDING A, UNIT A5 – A6, BOTANY QUARTER
NSW, 2019, AUSTRALIA
11-13 LORD ST, BOTANY
BUILDING A, UNIT A5 – A6, BOTANY QUARTER
NSW, 2019, AUSTRALIA
Regional and International offices
OUR WEBSITES
www.medlab.co
www.medlab.co
CONTACT DETAILS
OFFICE HOURS: 8:30AM - 5PM EST
AUS: 1300 369 570
AUS: +61 2 8188 0311
USA: +1 947 771 8119
UK: +44 20 8138 0311
FAX: +61 2 9699 3347
Email: hello@medlab.co
OFFICE HOURS: 8:30AM - 5PM EST
AUS: 1300 369 570
AUS: +61 2 8188 0311
USA: +1 947 771 8119
UK: +44 20 8138 0311
FAX: +61 2 9699 3347
Email: hello@medlab.co